The SABR (Stereotactic Ablative Radiotherapy) approach is a highly precise radiation therapy technique used to treat cancers, including lung cancer, with minimal damage to surrounding healthy tissue. Clinical oncologists with expertise in SABR focus on planning and delivering this treatment to patients with early-stage or oligometastatic lung cancer.

 

Key Aspects of SABR Expertise in Lung Cancer:

1.Patient Selection:

Assessing suitability for SABR, particularly for patients who are not candidates for surgery due to medical comorbidities or preference.

Evaluating tumor size, location, and proximity to critical structures like the heart, esophagus, or spinal cord.

​

2.Advanced Imaging and Planning:

Expertise in using imaging modalities like CT, MRI, and PET scans to delineate tumor boundaries.

Collaborating with radiologists to accurately map the tumor and surrounding critical structures.

​

3.Treatment Delivery:

Precision in delivering high doses of radiation over a few sessions (typically 3-8).

Ensuring accurate targeting using image guidance, motion management (to account for breathing), and immobilization techniques.

​

4.Multidisciplinary Care:

Working closely with thoracic surgeons, pulmonologists, and medical oncologists to ensure integrated care.

Discussing alternative therapies, such as immunotherapy or chemotherapy, if SABR is unsuitable.

​

5.Management of Side Effects:

Expertise in managing potential side effects, including radiation pneumonitis, chest wall pain, or rib fractures.

​

6.Research and Development:

Involvement in clinical trials to refine SABR protocols for lung cancer.

Staying updated on emerging techniques.